These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16639718)

  • 1. In vitro hemolysis: guidance for the pharmaceutical scientist.
    Amin K; Dannenfelser RM
    J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hydrophobic modification of polyelectrolytes as solubility enhancers in preparations for parenteral administration].
    Eisenmann G; Bauer KH
    Pharmazie; 1995 Mar; 50(3):191-4. PubMed ID: 7732050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations.
    Kalinkova GN
    Int J Pharm; 1999 Sep; 187(1):1-15. PubMed ID: 10502611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
    Nornoo AO; Osborne DW; Chow DS
    Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biocompatibility of parenteral vehicles--in vitro/in vivo screening comparison and the effect of excipients on hemolysis.
    Fu RC; Lidgate DM; Whatley JL; McCullough T
    J Parenter Sci Technol; 1987; 41(5):164-8. PubMed ID: 3694339
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of excipients on transporter mediated absorption.
    Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
    Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aqueous parenteral formulation of docetaxel using prodrugs.
    Park MH; Keum CG; Song JY; Kim D; Cho CW
    Int J Pharm; 2014 Feb; 462(1-2):1-7. PubMed ID: 24370840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an aqueous injection of ketoprofen.
    Singhai AK; Jain S; Jain NK
    Pharmazie; 1997 Feb; 52(2):149-51. PubMed ID: 9122274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hemolytic activity of undiluted organic water-miscible solvents for intravenous and intra-arterial injection.
    Mottu F; Stelling MJ; Rüfenacht DA; Doelker E
    PDA J Pharm Sci Technol; 2001; 55(1):16-23. PubMed ID: 11212416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What determines drug solubility in lipid vehicles: is it predictable?
    Rane SS; Anderson BD
    Adv Drug Deliv Rev; 2008 Mar; 60(6):638-56. PubMed ID: 18089295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.